Net profit of Senores Pharmaceuticals rose 141.97% to Rs 17.18 crore in the quarter ended December 2024 as against Rs 7.10 crore during the previous quarter ended December 2023. Sales rose 30.90% to Rs 103.02 crore in the quarter ended December 2024 as against Rs 78.70 crore during the previous quarter ended December 2023.
Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
Sales | 103.02 | 78.70 | 31 |
OPM % | 24.94 | 19.25 | - |
PBDT | 24.69 | 13.50 | 83 |
PBT | 20.49 | 10.25 | 100 |
NP | 17.18 | 7.10 | 142 |